VEGFA and vitreous hemorrhage: Vascular endothelial growth factor (VEGF) plays a central role in the development of PDR (11), and it has been demonstrated that intravitreal anti-VEGF decreases the need for repeated vitrectomy and recurrent vitreous hemorrhage (12, 13).